OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model

Aaron M. Sargeant, Robert C. Renge, Samuel K. Kulp, Russell D. Klein, Steven K. Clinton, Yu Chieh Wang, Ching Shih Chen

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the transgenic adenocarcinoma of the mouse prostate model'. Together they form a unique fingerprint.

Medicine & Life Sciences